<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v026708_ex99-1.txt
<TEXT>
RF INDUSTRIES, LTD.                                       For Immediate Release

RF Connectors/Aviel/Neulink/Bioconnect

Investor Contact:                                         Company Contact:
 Neil Berkman Associates                                  Howard F. Hill
 (310) 277 - 5162                                         President/CEO
 info@berkmanassociates.com                               (858) 549-6340


              RF Industries Repurchases, Retires 100,000 Options to
                             Purchase Common Shares


          SAN DIEGO, CA, October 3, 2005 . . . RF INDUSTRIES, LTD.,
      (NASDAQ:RFIL) today announced that on September 28, 2005, its Board of
      Directors entered into an agreement to repurchase, for $5.51 per option,
      in a single private transaction, 100,000 options to purchase RFI common
      stock at $.10 per share. The options, which were acquired from the
      Company's Chief Executive Officer, Howard Hill, are fully vested and could
      be exercised and sold by Mr. Hill at any time on the open market. If
      exercised, the repurchased options would have represented over 3% of RFI's
      outstanding stock. After retiring the options, the total number of RFI
      diluted common shares will decrease to approximately 3,700,000 shares. The
      purchase price of the options was computed using an average of 30 day's
      trading prices through September 28, 2005. On September 28, 2005, RFI
      common stock closed at $5.47 per share.

          As a consequence of repurchasing and retiring these options, RFI will
      incur a one-time, non-operating expense in the fourth quarter of the
      fiscal year ending October 31, 2005. This after-tax expense is projected
      at approximately $331,000, and is expected to reduce the company's fourth
      quarter and fiscal year earnings per share by approximately $0.09 per
      diluted share.

          "RFI's Board of Directors authorized the repurchase of these shares
      for a number of reasons. First, restrictions and volume requirements for
      repurchasing RFI's stock on the open market make this an attractive
      opportunity to reduce the total number of diluted shares outstanding,
      thereby raising future per share diluted earnings, avoiding future
      dilution to existing shareholders and raising the potential value of the
      stock as a currency for acquisitions. Second, most of the assets of RFI's
      CEO are comprised of his fully vested options which, according to SEC
      regulations, can only be sold in small quantities over a long period of
      time. Retiring these options obviates the effects on the Company's stock
      price of a single individual continually selling stock in small, open
      market transactions. Third, the repurchase reduces the dilutive effect of
      options previously granted to management and employees. Fourth, continuing
      low interest rates, combined with RFI's strong cash position and cash
      flow, lowers the benefits of holding large cash balances," said Linde
      Kester, Chairman of RF Industries.

<PAGE>

          At July 31, 2005, RFI reported cash and cash equivalents of
      $5,159,000, working capital of $10,446,000, an 18 to 1 current ratio, no
      long-term debt and stockholders' equity of $11,175,000, or $3.65 per
      outstanding share.

      About RF Industries

          RF Connectors designs and distributes radio frequency (RF) coaxial
      connectors and cable assemblies used for Wi-Fi, PCS, radio, test
      instruments, computer networks and antenna devices. Aviel Electronics
      provides custom microwave, and RF Connector solutions to aerospace, OEM
      and Government agencies. Neulink designs and markets wireless digital data
      transmission products for industrial monitoring, wide area networks, GPS
      tracking and locations systems. Bioconnect designs, manufactures and
      distributes specialized electrical cabling and interconnect products to
      the medical monitoring market.

      The statements contained in this release which are not historical facts
      may be deemed to contain forward-looking statements with respect to
      events, the occurrence of which involve risks and uncertainties,
      including, without limitation, uncertainties detailed in the Company's
      Securities and Exchange Commission filings.


</TEXT>
</DOCUMENT>
